STOCK TITAN

Aspira Women's Health (AWHL) CFO lists zero share ownership

(Neutral)
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Aspira Women's Health Inc. filed a Form 3 identifying John Strahley as Chief Financial Officer and a reporting person under SEC insider rules. The structured data shows no share transactions (0 buys, 0 sells) and zero holding entries, functioning as an administrative insider registration.

Positive

  • None.

Negative

  • None.
buyShares 0 Total buyShares reported in transactionSummary
sellShares 0 Total sellShares reported in transactionSummary
derivativeTransactionCount 0 Number of derivative-type records in transactionSummary
holdingEntries 0 Number of holding entries reported for the reporting person
reportingPersons regulatory
"Field "reportingPersons" lists individuals subject to insider reporting."
transactionSummary financial
"The "transactionSummary" aggregates counts of buys, sells and other actions."
derivativeSummary financial
""derivativeSummary" would show options or other derivative holdings if any existed."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Strahley John

(Last)(First)(Middle)
C/O ASPIRA WOMEN'S HEALTH INC.
12117 BEE CAVES RD BLDG 3-100

(Street)
AUSTIN, TEXAS 78738

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
04/27/2026
3. Issuer Name and Ticker or Trading Symbol
Aspira Women's Health Inc. [ AWHL ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Finacial Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
No securities are beneficially owned.
/s/ John Strahley07/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)